Microbiome R&d and Business Collaboration Congress: Asia
3rd Microbiome R&D and Business Collaboration Congress: Asia
R&D and business collaborations in microbiota research, probiotics, health and disease
Developments in the field of metagenomics have allowed researchers to explore the diverse microbiota in the human body. Research has shown that the microbiome is linked to natural immunity, metabolism, behavioural traits, and broadly speaking, plays an instrumental role in health and disease. With large-scale collaborative projects underway and sequencing data placed in the public domain, there is a rich source of information for researchers and companies looking for opportunities in this exciting field. Increasingly, there are indications that the human microbiome is key to curative and preventative medicine so efforts are being focused on expanding investment opportunities, performing more clinical trials and spurring innovative research in this area. Coupled with an increasing focus on healthy living and a therapeutics market that is expected to grow to $1.2 trillion by 2016, microbiome research is set to make waves in the science and medical world through its application in preventative treatments, cures, therapies and supplements.
Attracting experts working in all areas of microbiome research, product development and business, the congress will explore the interface between the microbiome and our evolving cultures and technologies. During the two-day conference, there will be networking breaks to promote interaction with your peers, expert led case study presentations, a dynamic exhibition room filled with technology providers showcasing their technologies and solutions, and panel discussions exploring key issues in the field.
•Gut Microbiota in Health & Disease
•Prebiotics & Diet
•Vaginal and Lung Microbiota
•Skin & Oral Microbiota
On Wednesday March 1, 2017 at 8:00 am (ends Thursday March 2, 2017 at 4:50 pm)
Category: Conferences - Science, Health & Medicine
Standard Fee : USD 1125